1. Home
  2. NMRA vs FSBW Comparison

NMRA vs FSBW Comparison

Compare NMRA & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • FSBW
  • Stock Information
  • Founded
  • NMRA 2019
  • FSBW 1936
  • Country
  • NMRA United States
  • FSBW United States
  • Employees
  • NMRA N/A
  • FSBW N/A
  • Industry
  • NMRA
  • FSBW Banks
  • Sector
  • NMRA
  • FSBW Finance
  • Exchange
  • NMRA Nasdaq
  • FSBW Nasdaq
  • Market Cap
  • NMRA 287.6M
  • FSBW 299.5M
  • IPO Year
  • NMRA 2023
  • FSBW 2012
  • Fundamental
  • Price
  • NMRA $0.66
  • FSBW $39.82
  • Analyst Decision
  • NMRA Buy
  • FSBW Hold
  • Analyst Count
  • NMRA 8
  • FSBW 1
  • Target Price
  • NMRA $9.29
  • FSBW $44.00
  • AVG Volume (30 Days)
  • NMRA 891.0K
  • FSBW 16.5K
  • Earning Date
  • NMRA 05-12-2025
  • FSBW 04-22-2025
  • Dividend Yield
  • NMRA N/A
  • FSBW 2.81%
  • EPS Growth
  • NMRA N/A
  • FSBW N/A
  • EPS
  • NMRA N/A
  • FSBW 4.36
  • Revenue
  • NMRA N/A
  • FSBW $139,150,000.00
  • Revenue This Year
  • NMRA N/A
  • FSBW $8.34
  • Revenue Next Year
  • NMRA N/A
  • FSBW $5.99
  • P/E Ratio
  • NMRA N/A
  • FSBW $9.20
  • Revenue Growth
  • NMRA N/A
  • FSBW 0.09
  • 52 Week Low
  • NMRA $0.62
  • FSBW $31.46
  • 52 Week High
  • NMRA $17.19
  • FSBW $49.15
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 31.99
  • FSBW 57.41
  • Support Level
  • NMRA $0.63
  • FSBW $38.00
  • Resistance Level
  • NMRA $0.72
  • FSBW $40.34
  • Average True Range (ATR)
  • NMRA 0.06
  • FSBW 0.93
  • MACD
  • NMRA 0.02
  • FSBW 0.10
  • Stochastic Oscillator
  • NMRA 18.80
  • FSBW 71.94

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: